Insomnio en niños con trastorno del espectro autista.
Saved in:
| Title: | Insomnio en niños con trastorno del espectro autista. |
|---|---|
| Alternate Title: | Insomnia in children with autism spectrum disorder. |
| Authors: | Flores, Melva Gissele1,2 (AUTHOR), Russi, María Eugenia2 (AUTHOR), Alonso, Xenia2 (AUTHOR), Sans Capdevila, Oscar1,2 (AUTHOR) oscarramon.sans@sjd.es |
| Source: | Medicina (Buenos Aires). 2026 Supplement 1, Vol. 86, p32-42. 11p. |
| Subjects: | SLEEP, AUTISM spectrum disorders, COGNITIVE ability, BEHAVIOR disorders in children, INSOMNIA, EMOTIONAL stability |
| Abstract (English): | In children and adolescents with autism spectrum disorder (ASD), an association has been identified be tween sleep problems, cognitive function, and affective dysregulation. This association exacerbates the core manifestations of autism and increases the risk of de veloping behavioral problems, irritability, hyperactivity, and inattention. The link between sleep problems and the central symptoms of ASD, along with their multiple associations with other health issues, demonstrates that addressing sleep problems from childhood improves physical and mental health, as well as cognitive and adaptive functioning. Medical treatment should fol low a stepped algorithm, starting with pediatric long-release melatonin (PRLM), followed by alimemazine, risperidone, and clonidine, depending on the patient's clinical response. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | El sueño en la infancia tiene implicaciones en el de sarrollo sináptico y en la maduración del cerebro de los niños. El sueño insuficiente se relaciona con problemas de salud, emocionales, conductuales y cognitivos. Los niños con trastorno del neurodesarrollo tienen una alta prevalencia de problemas de sueño (50-80%) frente al 25- 30% de los niños neurotípicos. En población infantojuve nil con trastorno del espectro del autismo (TEA), se ha identificado una asociación entre alteraciones del sueño, función cognitiva y desregulación afectiva. La evaluación diagnóstica debe ser sistemática y personalizada; debe incluir anamnesis, exploración física, agenda de sueño, analítica básica y herramientas validadas como cues tionarios de sueño, complementadas con pruebas neu rofisiológicas cuando sea necesario. Las intervenciones no farmacológicas constituyen la base del tratamiento. El tratamiento farmacológico debe seguir un algoritmo escalonado, comenzando con melatonina pediátrica de liberación prolongada (MPLP), seguida de alimemazina, risperidona y clonidina, según la respuesta clínica del paciente. [ABSTRACT FROM AUTHOR] |
| Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | MedicLatina |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
